007 - WARUNKOWE DOPUSZCZENIE

Warunkowe pozwolenie na dopuszczenie do obrotu (CMA - Conditional Marketing Authorisation) w kontekście preparatów genetycznych.

https://ec.europa.eu/commission/presscorner/detail/pl/QANDA_20_2390?fbclid=IwAR1mJMABJNRERiP6dZbQnaok4RDxuXMcy4lwLl_xA1ZGBYz5c4u5Uyp5sWw

https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/conditional-marketing-authorisation?fbclid=IwAR0Q4-9wWjt4kHutflSqPRQThT1nK_K0_IddjuuOfirgdQb0BF1MxUDE0HQ

https://www.ema.europa.eu/en/news/ema-receives-application-conditional-marketing-authorisation-covid-19-vaccine-astrazeneca?fbclid=IwAR0WkerpwGTBXdwNrS9uNJrgZYtWf2nSOjmm01sl555ttR4phXIyFxy-t_Y

https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu?fbclid=IwAR0282uBze-i_RGCzB9ZoSSoj43a3NO6PbknTnqGDWQKfv1X16PO7nZWAso

https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-janssen-authorisation-eu?fbclid=IwAR2C-qEITGkCrROZM-pus_Ug-eV_5g1DURU3lT-sZ-m2JdekuysTSFWJm4I

https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-moderna-authorisation-eu?fbclid=IwAR1mJMABJNRERiP6dZbQnaok4RDxuXMcy4lwLl_xA1ZGBYz5c4u5Uyp5sWw

https://edition.cnn.com/2021/04/13/health/johnson-vaccine-pause-cdc-fda/index.html?fbclid=IwAR2dGif18JssRhinzVwn45BNuPXuhJCEvS60fyY_Kc6HPXnrR6zTVoqa5rQ

https://arslege.pl/eksperyment-medyczny/k607/a48332/

https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/index.html?fbclid=IwAR2oLMjlqPFuASepL-8fwJLKIPZXbV2VvoqVK4T_FICc0QOrKO759OUwNX0